Ryan Langston
Stock Analyst at TD Cowen
(3.73)
# 2,089
Out of 5,162 analysts
281
Total ratings
55.5%
Success rate
4.9%
Average return
Main Sectors:
Stocks Rated by Ryan Langston
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Upgraded: Buy | $430 → $485 | $380.00 | +27.63% | 18 | Nov 20, 2026 | |
| UNH UnitedHealth Group | Upgraded: Buy | $402 → $455 | $330.48 | +37.68% | 21 | Nov 20, 2026 | |
| PIII P3 Health Partners | Rated: Hold | $13 → $4 | $1.86 | +115.05% | 13 | Nov 11, 2026 | |
| SGRY Surgery Partners | Reiterated: Hold | $24 → $25 | $26.69 | -6.33% | 15 | Nov 11, 2026 | |
| ASTH Astrana Health | Reiterated: Buy | $50 | $28.68 | +74.34% | 14 | Nov 9, 2026 | |
| ACHC Acadia Healthcare Company | Reiterated: Buy | $36 → $40 | $34.47 | +16.04% | 17 | Nov 6, 2026 | |
| ADUS Addus HomeCare | Rated: Buy | $131 → $145 | $121.07 | +19.77% | 24 | Nov 5, 2026 | |
| ALHC Alignment Healthcare | Rated: Buy | $12 → $10 | $6.50 | +53.85% | 12 | Nov 2, 2026 | |
| DVA DaVita | Rated: Buy | $220 → $228 | $156.34 | +45.84% | 14 | Nov 2, 2026 | |
| THC Tenet Healthcare | Reiterated: Buy | $263 → $302 | $263.59 | +14.57% | 10 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $140 → $150 | $132.28 | +13.40% | 5 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $65 | $65.58 | -0.88% | 19 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $197 | $174.98 | +12.58% | 18 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $460 → $486 | $460.33 | +5.58% | 18 | Oct 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $465 → $495 | $390.16 | +26.87% | 16 | Oct 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $55 → $95 | $89.50 | +6.15% | 11 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $230 → $200 | $203.34 | -1.64% | 19 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $24.69 | +21.51% | 12 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $391 → $333 | $273.04 | +21.96% | 4 | Feb 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $7 | $13.34 | n/a | 1 | Aug 9, 2024 |
Humana
Nov 20, 2026
Upgraded: Buy
Price Target: $430 → $485
Current: $380.00
Upside: +27.63%
UnitedHealth Group
Nov 20, 2026
Upgraded: Buy
Price Target: $402 → $455
Current: $330.48
Upside: +37.68%
P3 Health Partners
Nov 11, 2026
Rated: Hold
Price Target: $13 → $4
Current: $1.86
Upside: +115.05%
Surgery Partners
Nov 11, 2026
Reiterated: Hold
Price Target: $24 → $25
Current: $26.69
Upside: -6.33%
Astrana Health
Nov 9, 2026
Reiterated: Buy
Price Target: $50
Current: $28.68
Upside: +74.34%
Acadia Healthcare Company
Nov 6, 2026
Reiterated: Buy
Price Target: $36 → $40
Current: $34.47
Upside: +16.04%
Addus HomeCare
Nov 5, 2026
Rated: Buy
Price Target: $131 → $145
Current: $121.07
Upside: +19.77%
Alignment Healthcare
Nov 2, 2026
Rated: Buy
Price Target: $12 → $10
Current: $6.50
Upside: +53.85%
DaVita
Nov 2, 2026
Rated: Buy
Price Target: $220 → $228
Current: $156.34
Upside: +45.84%
Tenet Healthcare
Nov 2, 2026
Reiterated: Buy
Price Target: $263 → $302
Current: $263.59
Upside: +14.57%
Oct 30, 2026
Reiterated: Buy
Price Target: $140 → $150
Current: $132.28
Upside: +13.40%
Oct 29, 2026
Reiterated: Hold
Price Target: $65
Current: $65.58
Upside: -0.88%
Oct 29, 2026
Reiterated: Buy
Price Target: $197
Current: $174.98
Upside: +12.58%
Oct 28, 2026
Reiterated: Buy
Price Target: $460 → $486
Current: $460.33
Upside: +5.58%
Oct 23, 2026
Reiterated: Buy
Price Target: $465 → $495
Current: $390.16
Upside: +26.87%
Aug 7, 2026
Reiterated: Hold
Price Target: $55 → $95
Current: $89.50
Upside: +6.15%
Jul 27, 2026
Rated: Hold
Price Target: $230 → $200
Current: $203.34
Upside: -1.64%
May 11, 2026
Reiterated: Buy
Price Target: $30
Current: $24.69
Upside: +21.51%
Feb 4, 2026
Reiterated: Buy
Price Target: $391 → $333
Current: $273.04
Upside: +21.96%
Aug 9, 2024
Rated: Hold
Price Target: $7
Current: $13.34
Upside: n/a